Lichen International Limited
LICN
$4.41
$0.11912.78%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -1.90% | -1.90% | 13.63% | 13.63% | 34.99% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.90% | -1.90% | 13.63% | 13.63% | 34.99% |
| Cost of Revenue | -7.16% | -7.16% | 16.94% | 16.94% | 18.74% |
| Gross Profit | 1.50% | 1.50% | 11.57% | 11.57% | 48.06% |
| SG&A Expenses | 312.23% | 312.23% | 32.78% | 32.78% | 3.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 105.42% | 105.42% | 25.39% | 25.39% | 12.91% |
| Operating Income | -166.47% | -166.47% | -40.32% | -40.32% | 92.81% |
| Income Before Tax | -162.95% | -162.95% | -17.93% | -17.93% | 96.69% |
| Income Tax Expenses | -61.37% | -61.37% | 25.63% | 25.63% | 87.33% |
| Earnings from Continuing Operations | -198.65% | -198.65% | -43.48% | -43.48% | 100.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -198.93% | -198.93% | -43.48% | -43.48% | 100.20% |
| EBIT | -166.47% | -166.47% | -40.32% | -40.32% | 92.81% |
| EBITDA | -160.60% | -160.60% | -37.63% | -37.63% | 78.88% |
| EPS Basic | -164.55% | -164.55% | -51.27% | -51.27% | 69.94% |
| Normalized Basic EPS | -141.28% | -141.28% | -29.24% | -29.24% | 66.95% |
| EPS Diluted | -164.55% | -164.55% | -51.27% | -51.27% | 69.94% |
| Normalized Diluted EPS | -141.28% | -141.28% | -29.24% | -29.24% | 66.95% |
| Average Basic Shares Outstanding | 53.28% | 53.28% | 15.99% | 15.99% | 17.78% |
| Average Diluted Shares Outstanding | 53.28% | 53.28% | 15.99% | 15.99% | 17.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |